These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11679481)

  • 1. Human insulin analog insulin aspart does not cause insulin allergy.
    Yasuda H; Nagata M; Moriyama H; Fujihira K; Kotani R; Yamada K; Ueda H; Yokono K
    Diabetes Care; 2001 Nov; 24(11):2008-9. PubMed ID: 11679481
    [No Abstract]   [Full Text] [Related]  

  • 2. The insulin analog aspart: a safe alternative in insulin allergy.
    Airaghi L; Lorini M; Tedeschi A
    Diabetes Care; 2001 Nov; 24(11):2000. PubMed ID: 11679473
    [No Abstract]   [Full Text] [Related]  

  • 3. The human insulin analogue aspart is not the almighty solution for insulin allergy.
    Takata H; Kumon Y; Osaki F; Kumagai C; Arii K; Ikeda Y; Suehiro T; Hashimoto K
    Diabetes Care; 2003 Jan; 26(1):253-4. PubMed ID: 12502700
    [No Abstract]   [Full Text] [Related]  

  • 4. The human insulin analog aspart can induce insulin allergy.
    JiXiong X; Jianying L; Yulan C; Huixian C
    Diabetes Care; 2004 Aug; 27(8):2084-5. PubMed ID: 15277447
    [No Abstract]   [Full Text] [Related]  

  • 5. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin aspart: a review.
    Owens D; Vora J
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):793-804. PubMed ID: 17014395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin glulisine in the treatment of allergy to rapid acting insulin and its rapid acting analogs.
    Mollar-Puchades MA; Villanueva IL
    Diabetes Res Clin Pract; 2009 Jan; 83(1):e21-2. PubMed ID: 19070911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous allergy to insulin: could statins and ACE inhibitors play a role? A case report.
    Pitrola D; MacIver C; Mallipedhi A; Udiawar M; Price DE; Stephens JW
    Diabetes Res Clin Pract; 2014 Apr; 104(1):e20-2. PubMed ID: 24534533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE-mediated allergy to recombinant human insulin in a diabetic.
    Baur X; Bossert J; Koops F
    Allergy; 2003 Jul; 58(7):676-8. PubMed ID: 12823131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus.
    Chapman TM; Noble S; Goa KL
    Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lispro analog for treatment of generalized allergy to human insulin.
    Kumar D
    Diabetes Care; 1997 Sep; 20(9):1357-9. PubMed ID: 9283778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin aspart. Asp-B28, NovoRapid.
    Drugs R D; 1999 Aug; 2(2):103-6. PubMed ID: 10820650
    [No Abstract]   [Full Text] [Related]  

  • 13. Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes.
    Marusic S; Vlahovic-Palcevski V; Ljubanovic D
    Int J Clin Pharmacol Ther; 2009 Oct; 47(10):603-5. PubMed ID: 19825323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advantage of insulin lispro in suspected insulin allergy.
    Pánczél P; Hosszúfalusi N; Horváth MM; Horváth A
    Allergy; 2000 Apr; 55(4):409-10. PubMed ID: 10782533
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic allergic reaction by a human insulin analog.
    Barranco R; Herrero T; Tornero P; Barrio M; Frutos C; Rodríguez A; Malvetti V; Luisa Baeza M
    Allergy; 2003 Jun; 58(6):536-7. PubMed ID: 12757463
    [No Abstract]   [Full Text] [Related]  

  • 17. 2008 resource guide. Insulin. Along with human insulin analogs, recombinant DNA human insulins are the most widely used insulins in this country. Through genetic engineering, bacteria or yeast are transformed into little "factories" that produce synthetic human insulin.
    Diabetes Forecast; 2008 Jan; 61(1):RG11-4. PubMed ID: 18290288
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical pharmacokinetics and pharmacodynamics of insulin aspart.
    Lindholm A; Jacobsen LV
    Clin Pharmacokinet; 2001; 40(9):641-59. PubMed ID: 11605714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin detemir (levemir), a new long-acting insulin.
    Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin treatment of Type 2 diabetes: a clinical perspective.
    Bloomgarden Z; Drexler A; Handelsman Y
    J Diabetes; 2010 Jun; 2(2):65-6. PubMed ID: 20923487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.